1. Home
  2. KYIV vs ARQT Comparison

KYIV vs ARQT Comparison

Compare KYIV & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KYIV

Kyivstar Group Ltd.

N/A

Current Price

$12.88

Market Cap

2.9B

Sector

N/A

ML Signal

N/A

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

N/A

Current Price

$27.40

Market Cap

3.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KYIV
ARQT
Founded
1994
2016
Country
United Arab Emirates
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.2B
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
KYIV
ARQT
Price
$12.88
$27.40
Analyst Decision
Strong Buy
Buy
Analyst Count
8
8
Target Price
$18.87
★ $40.38
AVG Volume (30 Days)
590.4K
★ 2.5M
Earning Date
11-06-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 88.79
EPS
N/A
★ 0.09
Revenue
N/A
★ $376,072,000.00
Revenue This Year
$16.85
$44.19
Revenue Next Year
$7.95
$29.31
P/E Ratio
★ N/A
$290.56
Revenue Growth
N/A
★ 91.34
52 Week Low
$9.29
$19.30
52 Week High
$16.55
$34.80

Technical Indicators

Market Signals
Indicator
KYIV
ARQT
Relative Strength Index (RSI) 47.85 43.74
Support Level $11.25 $22.93
Resistance Level $14.14 $28.54
Average True Range (ATR) 0.49 1.51
MACD -0.01 -0.79
Stochastic Oscillator 17.29 20.53

Price Performance

Historical Comparison
KYIV
ARQT

About KYIV Kyivstar Group Ltd.

Kyivstar Group Ltd is a telecommunications and digital holding company that operates Ukraine provider of mobile communication and broadband services. The company offers a wide range of connectivity and digital services, including mobile and fixed-line voice and data, ride-hailing, e-health, digital TV, and enterprise solutions such as big data, cloud, and cybersecurity. It operates through two main segments: Telecommunications and Digital. The Telecommunications segment, which generates the majority of revenue, includes service revenue from mobile and fixed connectivity services provided to both individual and corporate customers. The Digital segment comprises revenue from proprietary digital platforms and services.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: